Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off


Industries with endless demand are great places to find dividend stocks. Healthcare might be the best example of this. No matter how much technology changes, the need to prevent and treat disease will never disappear. Sure, new treatments and solutions can change the game anytime, but the best players are the companies continually creating and innovating. How do you spot them? Well, you can look at those that have been doing it for a while already.

These blue chip stocks don't go on sale often, but you can circle them for the next time volatility hits Wall Street. Here are three fantastic healthcare stocks to target during the next market sell-off.

Pharmaceutical company (NYSE: ABBV) was formed when its sister company, Abbott Laboratories, spun it off in 2013. AbbVie's dividend roots go back decades before the split, and the company has raised its dividend every year since becoming its own corporation. Investors enjoyed robust years of dividend growth on the back of Humira, AbbVie's top drug. It spent years as a global top seller, and AbbVie's total sales doubled over the past decade.

Continue reading


Source Fool.com

AbbVie Inc. Aktie

175,02 €
-0,47 %
Heute verliert die AbbVie Inc. Aktie leicht an Boden, ein Rückgang von -0,47 %.
Einzigartige Zustimmung für AbbVie Inc. mit ausschließlich Buy-Einschätzungen.
Ein positives Kurspotenzial für AbbVie Inc. ist gegeben, mit einem Kursziel von 180 € über dem aktuellen Kurs von 175.02 €.
Like: 0
Teilen

Kommentare